GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (AQSE:ORPH) » Definitions » Cash Receipts from Tax Refunds

hVIVO (AQSE:ORPH) Cash Receipts from Tax Refunds


View and export this data going back to 2011. Start your Free Trial

What is hVIVO Cash Receipts from Tax Refunds?

Cash Receipts from Tax Refunds only applicable to companies reporting Cash Flow from Operations in direct method.


hVIVO Business Description

Industry
Traded in Other Exchanges
Address
40 Bank Street, Floor 24, London, GBR, E14 5NR
hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which is involved in the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.